Johannes R Vingerling Selected Research

Johannes R Vingerling Research Topics

Disease

21	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 05/2002
6	Glaucoma 11/2014 - 08/2007
6	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2012 - 04/2005
4	Refractive Errors (Refractive Error) 02/2022 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2006
4	Hemorrhage 01/2018 - 05/2002
3	Myopia 02/2022 - 12/2013
3	Macular Edema 01/2020 - 05/2002
3	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2018 - 08/2006
3	Ganglion Cysts (Ganglion) 11/2018 - 12/2012
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 12/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2010 - 07/2004
3	Diabetes Mellitus 06/2007 - 09/2003
2	Uveitis 11/2021 - 11/2020
2	Atrophy 11/2018 - 12/2017
2	Microaneurysm 07/2012 - 05/2002
2	Stroke (Strokes) 12/2010 - 12/2009
2	Vascular Diseases (Vascular Disease) 04/2008 - 01/2007
2	Hypertension (High Blood Pressure) 02/2006 - 06/2004
2	Atherosclerosis 07/2004 - 01/2003
1	Cicatrix (Scar) 11/2021
1	Retinal Diseases 11/2021
1	Retinal Vein Occlusion 01/2020
1	Vision Disorders (Hemeralopia) 01/2020
1	Melanoma (Melanoma, Malignant) 11/2018
1	Astigmatism 01/2018
1	Lacunar Stroke 12/2017
1	Myopia 2 01/2016
1	Cataract (Cataracts) 04/2015
1	Retinal Detachment (Retinal Detachments) 04/2015
1	Dementia (Dementias) 07/2012
1	Disease Progression 12/2011
1	Cerebral Hemorrhage 12/2010
1	Cerebral Infarction 12/2010
1	Vascular Depression 05/2010
1	Blindness (Hysterical Blindness) 03/2007
1	Glucose Intolerance 08/2006
1	Chronic Hepatitis B 07/2006

Drug/Important Bio-Agent (IBA)

22	Retinaldehyde (Retinal)IBA 02/2022 - 07/2004
5	Complement Factor H (Factor H)IBA 01/2017 - 07/2006
5	AntioxidantsIBA 03/2014 - 01/2003
5	CholesterolIBA 01/2012 - 04/2004
4	Apolipoproteins E (ApoE)IBA 01/2013 - 04/2004
2	Pharmaceutical PreparationsIBA 11/2021 - 06/2004
2	Fluorescein (Funduscein)FDA LinkGeneric 11/2021 - 05/2002
2	Ranibizumab (Lucentis)FDA Link 01/2020 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	Mydriatics (Cycloplegics)IBA 01/2019 - 05/2018
2	AnticoagulantsIBA 01/2018 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2011
2	Biological ProductsIBA 12/2013 - 10/2010
2	ApolipoproteinsIBA 01/2013 - 04/2004
2	P-2 (P 2)IBA 01/2012 - 12/2011
2	Complement System Proteins (Complement)IBA 03/2009 - 07/2006
2	Gliclazide (Diamicron)IBA 04/2008 - 01/2007
2	HDL CholesterolIBA 02/2006 - 09/2003
1	afliberceptIBA 11/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2018
1	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 11/2018
1	Acid PhosphataseIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 01/2018
1	LuteinIBA 01/2018
1	ZeaxanthinsIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2016
1	hydroxide ionIBA 01/2016
1	Infliximab (Remicade)FDA Link 12/2014
1	Monoclonal AntibodiesIBA 12/2014
1	LipidsIBA 09/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012
1	4-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA 08/2011
1	Protein Isoforms (Isoforms)IBA 06/2011
1	betaglycan (TGFBR3)IBA 06/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2011
1	ZincIBA 06/2011
1	Complement C5 (Complement 5)IBA 03/2010
1	neurotrophin 4IBA 10/2009
1	LigandsIBA 10/2009
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 03/2009
1	Complement C3 (C3 Complement)IBA 03/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008
1	Docosahexaenoic AcidsIBA 08/2008
1	Eicosapentaenoic AcidIBA 08/2008
1	perindopril drug combination indapamideIBA 04/2008
1	Estrogens (Estrogen)FDA Link 03/2007
1	DiureticsIBA 01/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2007
1	Perindopril FDA LinkGeneric 01/2007
1	Indapamide FDA LinkGeneric 01/2007
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2006
1	Lamivudine (Epivir)FDA Link 07/2006
1	Antihypertensive Agents (Antihypertensives)IBA 02/2006
1	C-Reactive ProteinIBA 02/2006

Therapy/Procedure

3	Therapeutics 01/2012 - 07/2006
1	Intravitreal Injections 01/2020
1	Slit Lamp 11/2018
1	Refractive Surgical Procedures 04/2015
1	Lasers (Laser) 07/2012